stock · yahoo

UnitedHealth Group Incorporated

UNH

$401.43
▼ 5.24 (-1.29%)
polled · warming up

Below: live stock price for UnitedHealth Group Incorporated (UNH), a 1-year chart, 8 indicators (RSI, MACD, Bollinger, MA, EMA, Stochastic, ATR, Volume), and a compare mode. Add to your portfolio, star to your watchlist, or set a price alert in one place.

UnitedHealth Group Incorporated (UNH) is a Healthcare company based in United States. Operating in Healthcare Plans, it employs about 390,000 people. Over the past year UNH traded between 255.97 and 461.62 USD. Trailing P/E sits near 25.82 on a market cap of about 360.32B USD. It currently yields 2.31% in dividends.

Day
-1.29%
-5.24
Week
+5.83%
+22.13
Month
+6.51%
+24.53
Year
—
Prev close
$406.67
Volume (24h)
$3.25B
Market cap
$360.32B
Currency
USD

Score

47/ 100 · Mixed

Coverage: 7/7
  • Value60
  • Quality37
  • Momentum40
  • Growth64
  • Risk77
  • Dividend46
  • Liquidity6

Composite of public market data. Informational only — not investment advice.

Trend projection

Where the recent trend points if it continues.

DowntrendFit 62%Pace -0.18% per bar
+5 bars+20 bars+60 bars+120 bars
+5 bars
398.5892
-0.71%
Bull446.1906
Bear356.066
+20 bars
394.7024
-1.68%
Bull494.6064
Bear314.9778
+60 bars
393.209
-2.05%
Bull581.2286
Bear266.0112
+120 bars
393.1543
-2.06%
Bull683.2638
Bear226.2235

Linear-regression continuation — not a prediction, not investment advice. ±1σ ≈ 68% range · ±2σ ≈ 95% range: ±0.0252 USD.

Interpretation

Composite signals look mixed. Strength: risk profile with weakness: balance-sheet liquidity. Price sits in the middle of the recent range, trend is sloping downward.

Descriptive observation — not investment advice.

Score breakdown

Raw values behind each pillar so you can see what the composite is reading.

  • Value
    60/100

    Value looks solid — driven by P/E (25.82).

    P/E:25.82P/B:3.48PEG:1.06
  • Quality
    37/100

    Quality looks weak — driven by Gross margin (20.05%).

    ROE:15.77%ROA:5.24%Profit margin:3.53%Gross margin:20.05%
  • Momentum
    40/100

    Momentum looks weak — driven by 52w change (10.14%).

    52w change:10.14%
  • Growth
    64/100

    Growth looks solid — driven by Earnings growth (75.90%).

    Revenue growth:-0.40%Earnings growth:75.90%
  • Risk
    77/100

    Risk looks strong — driven by Debt / equity (70.43).

    Beta:0.62Debt / equity:70.43Short interest:1.98%
  • Dividend
    46/100

    Dividend looks mixed — driven by Payout ratio (57.56%).

    Dividend yield:2.31%Payout ratio:57.56%
  • Liquidity
    6/100

    Liquidity looks fragile — driven by Current ratio (0.74).

    Current ratio:0.74Quick ratio:0.42

Derived from public market data — informational, not investment advice.

Price report

How this asset has actually moved over the last 250 days.

Position in range71%
255.97 low461.62 high

Where the price sits between the window low and high.

Volatility (annualised)
35.9%

Spread of returns. Higher means larger swings in both directions.

Max drawdown
-29.6%

Worst peak-to-trough fall inside the window.

Below period high
-13.0%

Current price against the highest point in the window.

Best day
+9.37%
Worst day
-19.61%
Up days
47%

Share of days that closed above the one before.

Current streak
1 down
Typical day swing
2.6%

Average high-to-low spread within a single day.

Volume vs average
+15%

Last 10 days against the whole window.

Descriptive statistics over past prices — not a forecast and not investment advice.

Reference levels

Fibonacci retracements and extensions across the recent range.

60 bars

Reference only — not investment advice.

These coordinates describe past-trade clustering, not where to buy or sell. Do your own research before any trade.

Next level above
405.2914 USD+0.96%
Fib 38.2% retracement
Next level below
397.14 USD-1.07%
Fib 50% midpoint

Levels derived from: 431.68 high → 362.6 low · 60 bars

  • Resistance
    Fib +161.8% extension
    not reached
    543.4514 USD
    +35.38% from current
  • Resistance
    Fib +100% extension
    not reached
    500.76 USD
    +24.74% from current
  • Resistance
    Fib +61.8% extension
    not reached
    474.3714 USD
    +18.17% from current
  • Resistance
    Fib +27.2% extension
    not reached
    450.4697 USD
    +12.22% from current
  • Resistance
    Fib 23.6% retracement
    tested 8×
    415.3771 USD
    +3.47% from current
  • Resistance
    Fib 38.2% retracementNearest
    tested 10×
    405.2914 USD
    +0.96% from current
  • Current
    401.43 USD
  • Support
    Fib 50% midpoint
    tested 16×
    397.14 USD
    -1.07% from current
  • Support
    Fib 61.8% retracement
    tested 9×
    388.9886 USD
    -3.10% from current
  • Support
    Fib 78.6% retracement
    tested 15×
    377.3831 USD
    -5.99% from current
  • Support
    Fib −27.2% extension
    not reached
    343.8102 USD
    -14.35% from current
  • Support
    Fib −61.8% extension
    not reached
    319.9086 USD
    -20.31% from current
  • Support
    Fib −100% extension
    not reached
    293.52 USD
    -26.88% from current
How to read this

We take the highest and lowest price of the last 60 bars and cut the gap between them at the classic Fibonacci ratios (23.6%, 38.2%, 50%, 61.8%, 78.6%), plus extensions beyond both ends.

“Tested N×” counts how many of those 60 bars actually traded through the level. A level price has crossed many times is one the market has repeatedly agreed on; a level at 0 is pure geometry the price has never reached.

This is a map of where trading has already happened — not a forecast and not a signal. Price moves through these levels all the time.

Financials

52w high
$461.62
52w low
$255.97
52w change
10.14%
Day high
$412.17
Day low
$395.52
P/E (TTM)
25.82
Forward P/E
17.28
PEG
1.06
Price / Book
3.48
Beta (5Y)
0.62
Enterprise value
409.29B
EV / Revenue
0.91
EV / EBITDA
14.16
EPS (TTM)
$15.55
Forward EPS
$23.23
Dividend yield
2.31%
Dividend rate
$9.28
Payout ratio
57.56%
Revenue (TTM)
450.06B
EBITDA
28.9B
Free cash flow
26.5B
Total cash
28.55B
Total debt
74.33B
Debt / Equity
70.43
Current ratio
0.74
Quick ratio
0.42
Profit margin
3.53%
Gross margin
20.05%
Return on assets
5.24%
Return on equity
15.77%
Shares outstanding
897.59M
Float
899.41M
Sector: HealthcareIndustry: Healthcare PlansHQ: United StatesEmployees: 390Kwww.unitedhealthgroup.com

UnitedHealth Group Incorporated operates as a health care company in the United States and internationally. It operates through four segments: Optum Health, Optum Insight, Optum Rx; and UnitedHealthcare. The Optum Health segment provides care delivery, care management, wellness and consumer engagement, and health financial services with patients, consumers, care delivery systems, providers, employers, payers, and public-sector entities. The Optum Insight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, public entities, life sciences companies and other organizations. The Optum Rx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and community health pharmacy services, infusion, and purchasing and clinical capabilities, as well as develops programs in the areas of step therapy, formulary management, drug adherence, and disease and drug therapy management. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; Medicaid plans, including Temporary Assistance to Needy Families; Children's Health Insurance Programs; Dual SNPs; Long-Term Services and Supports; Aged, Blind and Disabled; and other federal, state, and community health care programs. and health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage. UnitedHealth Group Incorporated was founded in 1974 and is based in Eden Prairie, Minnesota.

Analyst & Risk

Consensus
Buy
Mean rating1.58 / 5
Analysts25
Next earnings2027-01-12
Strong buy 7Buy 15Hold 4
Analyst price target
$477.04
Mean target · 25 analysts
+18.8%
upside
Low $380.00Now $401.43High $529.00
Beta (vs S&P 500)
0.62
less volatile
52-week change
10.14%
Short % of float
1.98%
Short ratio (days)
3.11
Debt / Equity
70.43
very high leverage
Current ratio
0.74
Quick ratio
0.42
ROE
15.77%
ROA
5.24%
PEG ratio
1.06
fair
EV / Revenue
0.91
EV / EBITDA
14.16
Revenue growth
-0.40%
Earnings growth
75.90%
EBITDA
28.9B
Free cash flow
26.5B
Total cash
28.55B
Total debt
74.33B
Insider holdings
0.25%
Institutional
89.66%

Recent rating changes

  • 2026-10-16BernsteinOutperform → Outperformmain
  • 2026-10-16JP MorganOverweight → Overweightmain
  • 2026-10-15TD CowenHold → Holdreit
  • 2026-10-14Piper SandlerOverweight → Overweightmain
  • 2026-10-14BarclaysOverweight → Overweightmain
  • 2026-10-14BairdNeutral → Neutralmain
  • 2026-10-09TD CowenHold → Holdmain
  • 2026-07-21JP MorganOverweight → Overweightmain

Recent news

Related

Other assets in this category.

Learn the terms

Live discussion

Sign in to join the discussion.

  • No comments yet. Be the first.